Afghanistan vs Brazil: The number of people with susceptibility test result for rifampicin
Afghanistan
17,443
in 2021
Brazil
24,394
in 2021
Afghanistan rank
16th
Brazil rank
14th
The number of people with susceptibility test result for rifampicin over time
- Afghanistan
- Brazil
How they compare
Brazil currently reports 24,394 against 17,443 in Afghanistan, a difference of 6,951.
That makes Brazil's figure about 1.4 times Afghanistan's.
Across all 5 years both countries report, Brazil has been ahead every year.
Afghanistan ranks 16th and Brazil ranks 14th of 155 countries.
Brazil has averaged higher in every one of the 2 decades both report.
Head to head by decade
| Decade | Afghanistan | Brazil | Difference | Ahead |
|---|---|---|---|---|
| 2010s | 6,121 | 20,251 | 14,129 | Brazil |
| 2020s | 13,849 | 24,076 | 10,228 | Brazil |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher the number of people with susceptibility test result for rifampicin, Afghanistan or Brazil?
- Brazil, at 24,394 against 17,443 in Afghanistan as of 2021.
- What is the difference in the number of people with susceptibility test result for rifampicin between Afghanistan and Brazil?
- 6,951, with Brazil ahead.
- How many years of comparable data are there for Afghanistan and Brazil?
- 5 years are reported by both, from 2017 to 2021.
- How do Afghanistan and Brazil rank globally for the number of people with susceptibility test result for rifampicin?
- Afghanistan ranks 16th and Brazil ranks 14th of 155 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as The number of people with susceptibility test result for rifampicin among bacteriologically confirmed pulmonary TB patients.. Statizoid refreshes it automatically from the source and publishes the full history for both places.